Click here for Analysts' Upgrades, Downgrades.
Editor's Note: Green and red arrows refer to intraday stock price movement.
NEW YORK (
STOCK COMMENTS / EPS CHANGES
Alexander & Baldwin
(ALEX - Get Report) estimates were boosted through 2012 at Goldman Sachs. Company is benefiting from better shipping rates. Neutral rating and new $38 price target.
(ATML - Get Report)
estimates, target raised at Goldman Sachs. Shares now seen reaching $7.25. Estimates also increased, as the company is realizing higher margins. Neutral rating.
(AWR - Get Report)
numbers upped at Goldman Sachs. Estimates were boosted through 2012, Goldman Sachs said. Company is seeing higher rates and volumes. Neutral rating and new $26 price target.
(CBOE - Get Report)
numbers boosted at Goldman Sachs. Shares now seen reaching $25. Estimates were also upped, given better volume trends. Neutral rating.
numbers lowered at Goldman Sachs. Shares now seen reaching $34. Estimates also cut, as the company is seeing lower margins. Neutral rating.
price target raised at Credit Suisse. LIZ price target improved by a dollar to $7. Turnaround on track but problem with inventory build, Credit Suisse said. Maintain Neutral rating.
(MHK - Get Report)
numbers reduced at UBS. Estimates were cut through 2011, UBS said. Company is seeing lower sales and margins. Buy rating and new $75 price target.
numbers boosted at Goldman. Shares of MTD now seen reaching $141, according to Goldman Sachs. Estimates also upped, given higher organic sales growth for the lab and industrials business segments. Neutral rating.
estimates, target lowered at Goldman. Shares of N now seen reaching $19, according to Goldman Sachs. Estimates also cut, given lower billings. Neutral rating.
price target higher at Credit Suisse. PCS price target raised to $13 from $11 on solid earnings, Credit Suisse said. Maintain Neutral rating.
estimates, target upped at Goldman Sachs. SAPE estimates were boosted through 2012, Goldman Sachs said. Company is generating solid organic growth. Buy rating and new $15.50 price target.
estimates, target raised at UBS. Shares of SBUX now seen reaching $33, according to UBS. Estimates also increased, given continued core business growth. Buy rating.
numbers increased at Goldman Sachs. SNI estimates were raised through 2012, according to Goldman Sachs. Company is seeing better advertising demand. Neutral rating and new $50 price target.
numbers boosted at UBS. Shares of SWKS now seen reaching $28, according to UBS. Estimates also upped, as the company should continue to have solid earnings momentum. Buy rating.
numbers raised at Goldman Sachs. Shares of TRW now seen reaching 2012, according to Goldman Sachs. Estimates also increased, as higher chassis sales are driving margin growth. Neutral rating.
Check Out Our Best Services for Investors
Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts